These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
15. Sex Differences in Nociceptin/Orphanin FQ Peptide Receptor-Mediated Pain and Anxiety Symptoms in a Preclinical Model of Post-traumatic Stress Disorder. Zhang Y; Schalo I; Durand C; Standifer KM Front Psychiatry; 2018; 9():731. PubMed ID: 30670988 [TBL] [Abstract][Full Text] [Related]
16. Role of nociceptin/orphanin FQ and nociceptin opioid peptide receptor in depression and antidepressant effects of nociceptin opioid peptide receptor antagonists. Park JY; Chae S; Kim CS; Kim YJ; Yi HJ; Han E; Joo Y; Hong S; Yun JW; Kim H; Shin KH Korean J Physiol Pharmacol; 2019 Nov; 23(6):427-448. PubMed ID: 31680765 [TBL] [Abstract][Full Text] [Related]
17. The Nociceptin/Orphanin FQ peptide receptor antagonist, SB-612111, improves cerebral blood flow in a rat model of traumatic brain injury. Al Yacoub ON; Tarantini S; Zhang Y; Csiszar A; Standifer KM Front Pharmacol; 2023; 14():1272969. PubMed ID: 37920208 [TBL] [Abstract][Full Text] [Related]
18. The nociceptin/orphanin FQ antagonist UFP-101 differentially modulates the glucocorticoid response to restraint stress in rats during the peak and nadir phases of the hypothalamo-pituitary-adrenal axis circadian rhythm. Leggett JD; Jessop DS; Fulford AJ Neuroscience; 2007 Jul; 147(3):757-64. PubMed ID: 17574767 [TBL] [Abstract][Full Text] [Related]
19. Effects of non-peptide nociceptin/orphanin FQ receptor ligands on methylphenidate-induced hyperactivity in mice: Implications for bipolar disorders. Asth L; Tiago PRF; Costa LRF; Holanda VAD; Pacifico S; Zaveri NT; Calo' G; Ruzza C; Gavioli EC Neuropeptides; 2020 Aug; 82():102059. PubMed ID: 32600667 [TBL] [Abstract][Full Text] [Related]
20. Pharmacological and genetic evidence for pre- and postsynaptic D2 receptor involvement in motor responses to nociceptin/orphanin FQ receptor ligands. Viaro R; Calcagno M; Marti M; Borrelli E; Morari M Neuropharmacology; 2013 Sep; 72():126-38. PubMed ID: 23643745 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]